PROGRAM

TCT 2019 will feature a host of sponsored satellite programs offering attendees comprehensive insights into important interventional topics and issues facing interventional specialists. 

Sponsored sessions include breakfast programs, lunchtime Presentation Theater programs, and evening programming. 

Satellite Programs

Expanding Applications for Intravenous Platelet Inhibition

Evening Program

09/27/2019 18:30:00 09/27/2019 20:00:00 Expanding Applications for Intravenous Platelet Inhibition TCT 2017 true MM/DD/YYYY TCT 2014 Satellite Symposia - Evening Program

Friday, September 27, 2019
Reception: 6:00 pm  | 
Program: 6:30 pm-8:00 pm
San Francisco Marriott Marquis, Yerba Buena Ballroom 7, Lower B2 Level

Expanding Applications for Intravenous Platelet Inhibition

Expanding Applications for Intravenous Platelet Inhibition

Sponsored by Cardiovascular Research Foundation

Supported through an educational grant from Chiesi USA, Inc.

The Cardiovascular Research Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Cardiovascular Research Foundation designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Chairs  

Robert A. Harrington, MD

Stanford University School of Medicine

Stanford, CA

 

Gregg W. Stone, MD

NewYork-Presbyterian/ Columbia University Medical Center

New York, NY

Faculty  

Dominick J. Angiolillo, MD, PhD

University of Florida

Jacksonville, FL

 

Francesco Franchi, MD, ChB, MD

University of Florida

Jacksonville, FL

 

Roxana Mehran, MD

Icahn School of Medicine at Mount Sinai

New York, NY

Agenda

6:30 pm

Which Patients Are (and Are Not) Candidates for Intravenous Platelet Inhibition During PCI?

Gregg W. Stone

6:40 pm

Roundtable Discussion With Audience Q&A

6:43 pm

Intravenous Platelet Inhibition for PCI: Drug Description and Clinical Outcomes From Randomized Trials and Registries

Robert A. Harrington

6:58 pm

Roundtable Discussion With Audience Q&A

7:03 pm

Intravenous Platelet Inhibition for PCI and Bridging: Duration, Oral Drug Conversion and More

Dominick J. Angiolillo

7:15 pm

Roundtable Discussion With Audience Q&A

7:19 pm

Case #1 Introduction: PCI in a Patient With ACS

7:22 pm

Roundtable Discussion: How Should We Treat This Patient?

7:27 pm

Case #1 Resolution: How Did We Treat This Patient? What Might We Have Done Differently

7:32 pm

Case #2 Introduction: Intravenous Platelet Inhibition During PCI in Complex Stable CAD

Francesco Franchi

7:35 pm

Roundtable Discussion: How Should We Treat This Patient?

7:40 pm

Case #2 Resolution: How Did We Treat This Patient? What Might We Have Done Differently

Francesco Franchi

7:45 pm

Case #3 Introduction: A Case in Which We Might Consider Bridging

Roxana Mehran

7:48 pm

Roundtable Discussion: How Should We Treat This Patient?

7:53 pm

Case #3 Resolution: How Did We Treat This Patient? What Might We Have Done Differently

Roxana Mehran

7:58 pm

Take-home Messages: The Expanding Role of Intravenous Platelet Inhibition for PCI

Robert A. Harrington, Gregg W. Stone

8:00 pm

Adjourn

8:01 pm

Adjourn